Next Article in Journal
Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival
Previous Article in Journal
Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer
Open AccessArticle

Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours

1
Endocrine Signalling Group, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK
2
Comparative Biomedical Sciences, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK
3
Clinical Sciences & Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire AL9 7TA, UK
4
Department of Translational Science, Bristol Medical School, University of Bristol, Whitson Street, Bristol BS1 3NY, UK
5
Small Animal Specialist Hospital, 1 Richardson Place, North Ryde, 2113 NSW, Australia
6
Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, Bünteweg 9, 30559 Hannover, Germany
7
Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(3), 1076; https://doi.org/10.3390/ijms22031076
Received: 17 December 2020 / Revised: 14 January 2021 / Accepted: 20 January 2021 / Published: 22 January 2021
(This article belongs to the Section Molecular Endocrinology and Metabolism)
Patients harbouring mutations in genes encoding C-type natriuretic peptide (CNP; NPPC) or its receptor guanylyl cyclase B (GC-B, NPR2) suffer from severe growth phenotypes; loss-of-function mutations cause achondroplasia, whereas gain-of-function mutations cause skeletal overgrowth. Although most of the effects of CNP/GC-B on growth are mediated directly on bone, evidence suggests the natriuretic peptides may also affect anterior pituitary control of growth. Our previous studies described the expression of NPPC and NPR2 in a range of human pituitary tumours, normal human pituitary, and normal fetal human pituitary. However, the natriuretic peptide system in somatotropes has not been extensively explored. Here, we examine the expression and function of the CNP/GC-B system in rat GH3 somatolactotrope cell line and pituitary tumours from a cohort of feline hypersomatotropism (HST; acromegaly) patients. Using multiplex RT-qPCR, all three natriuretic peptides and their receptors were detected in GH3 cells. The expression of Nppc was significantly enhanced following treatment with either 100 nM TRH or 10 µM forskolin, yet only Npr1 expression was sensitive to forskolin stimulation; the effects of forskolin and TRH on Nppc expression were PKA- and MAPK-dependent, respectively. CNP stimulation of GH3 somatolactotropes significantly inhibited Esr1, Insr and Lepr expression, but dramatically enhanced cFos expression at the same time point. Oestrogen treatment significantly enhanced expression of Nppa, Nppc, Npr1, and Npr2 in GH3 somatolactotropes, but inhibited CNP-stimulated cGMP accumulation. Finally, transcripts for all three natriuretic peptides and receptors were expressed in feline pituitary tumours from patients with HST. NPPC expression was negatively correlated with pituitary tumour volume and SSTR5 expression, but positively correlated with D2R and GHR expression. Collectively, these data provide mechanisms that control expression and function of CNP in somatolactotrope cells, and identify putative transcriptional targets for CNP action in somatotropes. View Full-Text
Keywords: CNP; multiplex RT-qPCR; pituitary; somatotrope; acromegaly; feline CNP; multiplex RT-qPCR; pituitary; somatotrope; acromegaly; feline
Show Figures

Figure 1

MDPI and ACS Style

Mirczuk, S.M.; Scudder, C.J.; Read, J.E.; Crossley, V.J.; Regan, J.T.; Richardson, K.M.; Simbi, B.; McArdle, C.A.; Church, D.B.; Fenn, J.; Kenny, P.J.; Volk, H.A.; Wheeler-Jones, C.P.; Korbonits, M.; Niessen, S.J.; McGonnell, I.M.; Fowkes, R.C. Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours. Int. J. Mol. Sci. 2021, 22, 1076. https://doi.org/10.3390/ijms22031076

AMA Style

Mirczuk SM, Scudder CJ, Read JE, Crossley VJ, Regan JT, Richardson KM, Simbi B, McArdle CA, Church DB, Fenn J, Kenny PJ, Volk HA, Wheeler-Jones CP, Korbonits M, Niessen SJ, McGonnell IM, Fowkes RC. Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours. International Journal of Molecular Sciences. 2021; 22(3):1076. https://doi.org/10.3390/ijms22031076

Chicago/Turabian Style

Mirczuk, Samantha M.; Scudder, Christopher J.; Read, Jordan E.; Crossley, Victoria J.; Regan, Jacob T.; Richardson, Karen M.; Simbi, Bigboy; McArdle, Craig A.; Church, David B.; Fenn, Joseph; Kenny, Patrick J.; Volk, Holger A.; Wheeler-Jones, Caroline P.; Korbonits, Márta; Niessen, Stijn J.; McGonnell, Imelda M.; Fowkes, Robert C. 2021. "Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours" Int. J. Mol. Sci. 22, no. 3: 1076. https://doi.org/10.3390/ijms22031076

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop